SISRAM Med 1696

SISRAM Med 1696

Postby winston » Wed Aug 22, 2018 11:02 am

not vested

Analysis:

SISRAM MED(1696) is principally engaged in the design, development, manufacture and sale of energy-based aesthetic medical and minimally invasive treatment system.

The Group is focusing on three major hot spots : body contouring, dermatology (skin rejuvenation in specific) and feminine health.

It started in 2018 implementing its " Go East" strategy, delivering the best of the west to the east by utilizing its technological and operational strengths as an industry leader.

For the six months ended 30 June 2018, the Group`s revenue increased 17.9% to US$78.2 million as compared to the corresponding period in 2017 and net profit attributable to shareholders increased 43.9% to US$11.3 million.(I do not hold the above stock)

Strategy:
Buy-in Price: $4.80, Target Price: $5.50, Cut Loss Price: $4.45

Source: Phillips
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118539
Joined: Wed May 07, 2008 9:28 am

Return to S to Z

Who is online

Users browsing this forum: No registered users and 8 guests

cron